📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
13%
💰 Capital Raise
18%
• Active ATM program with $75M remaining capacity
🔁 Convertible Conversion
15%
• Convertible debt present: 8.1% potential dilution
💹 Market Data
Market Cap$221.35M
Shares Outstanding59.44M
Float28.41M
Cash$56.60M
Debt$120.67M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 17.2% shares (2026Q1 vs prior)
50 institutional holders · 4.43M shares
#1
VANGUARD GROUP INC
1.51M shares
#2
CITADEL ADVISORS LLC
591.4K shares
#3
BlackRock, Inc.
428.6K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.72M
Days to Cover6.7
% of Float6.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
8-K
8K EVENT
Mar 11, 2026
424B5
ATM
Mar 10, 2026
424B5
ATM
Mar 06, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for VENU
📊 VENU FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 VENU Signal Convergence & Dark Pool Activity — StonkWhisper
📄 VENU Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.